Invitrogen

CD274 (PD-L1, B7-H1) Monoclonal Antibody (MIH5), PE-Cyanine7, eBioscience™

Advanced Verification

This Antibody was verified by Cell treatment to ensure that the antibody binds to the antigen stated.

36 Published Figures

38 References

View all (230) PD-L1 (CD274) antibodies

Datasheet

Protocols

Questions & Answers

Datasheet

Protocols

Questions & Answers

CD274 (PD-L1, B7-H1) Antibody in Flow Cytometry (Flow)

FIGURE: 1 / 38

CD274 (PD-L1, B7-H1) Antibody (25-5982-82) in Flow

Staining of C57Bl/6 splenocytes with Anti-Mouse CD3 eFluor® 450 (Product # 48-0032-82) and 0.06 µg of Rat IgG2a K Isotype Control PE-Cyanine7 (Product # 25-4321-82) (left) or 0.06 µg of Anti-Mouse CD274 (B7-H1) PE-Cyanine7 (right). Cells in the lymphocyte gate were used for analysis.

Product Image Gallery

Product Details

25-5982-82

Applications

Tested Dilution

Publications

Flow Cytometry (Flow)

0.125 µg/test

View 38 publications 38 publications

Product Specifications

Species Reactivity

Mouse

Published species

Human, Mouse

Host/Isotype

Rat / IgG2a, lambda

Recommended Isotype Control

Rat IgG2a kappa Isotype Control (eBR2a), PE-Cyanine7, eBioscience™

Class

Monoclonal

Type

Antibody

Clone

MIH5

Conjugate

PE-Cyanine7 PE-Cyanine7 PE-Cyanine7

Excitation/Emission Max

569/780 nm View spectra

Form

Liquid

Concentration

0.2 mg/mL

Purification

Affinity chromatography

Storage buffer

PBS, pH 7.2

Contains

0.09% sodium azide

Storage conditions

4° C, store in dark, DO NOT FREEZE!

Shipping conditions

Ambient (domestic); Wet ice (international)

RRID

AB_2573509

Product Specific Information

Description: The MIH5 monoclonal antibody reacts with mouse B7-H1, also known as PD-L1. B7-H1, a member of the B7 family, has a predicted molecular weight of approximately 40 kDa and belongs to the Ig superfamily. B7-H1 is expressed on a majority of leukocytes including T, B, NK and DC. B7-H1 is a ligand for PD-1. Interaction of PD-1 with either PD-L1 (B7-H1) or PD-L2 (B7-DC) results in inhibition of T and B cell responses. MIH5 is reported to be a blocking antibody.

Applications Reported: This MIH5 antibody has been reported for use in flow cytometric analysis.

Applications Tested: This MIH5 antibody has been tested by flow cytometric analysis of mouse splenocytes. This can be used at less than or equal to 0.125 µg per test. A test is defined as the amount (µg) of antibody that will stain a cell sample in a final volume of 100 µL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.

Light sensitivity: This tandem dye is sensitive to photo-induced oxidation. Please protect this vial and stained samples from light.

Fixation: Samples can be stored in IC Fixation Buffer (Product # 00-822-49) (100 µL of cell sample + 100 µL of IC Fixation Buffer) or 1-step Fix/Lyse Solution (Product # 00-5333-54) for up to 3 days in the dark at 4°C with minimal impact on brightness and FRET efficiency/compensation. Some generalizations regarding fluorophore performance after fixation can be made, but clone specific performance should be determined empirically.

Excitation: 488-561 nm; Emission: 775 nm; Laser: Blue Laser, Green Laser, Yellow-Green Laser.

Filtration: 0.2 µm post-manufacturing filtered.

Target Information

Programmed death receptor ligand 1 (PD-L1, also called B7-H1) is a recently described B7 family member. To date, one specific receptor has been identified that can be ligated by PD-L1. This receptor, programmed death receptor 1 (PD-1), has been shown to negatively regulate T-cell receptor (TCR) signaling. Upon ligating its receptor, PD-L1 has been reported to decrease TCR-mediated proliferation and cytokine production. PD-L1 expression was found to be abundant on many murine and human cancers and could be further up-regulated upon IFN-gamma stimulation. Thus, PD-L1 might play an important role in tumor immune evasion.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

How to use the Panel Builder

Watch the video to learn how to use the Invitrogen Flow Cytometry Panel Builder to build your next flow cytometry panel in 5 easy steps.

Product References

AR-A014418 regulates intronic polyadenylation and transcription of PD-L1 through inhibiting CDK12 and CDK13 in tumor cells.

Journal for immunotherapy of cancer

Zhang G,Lan B,Zhang X,Lin M,Liu Y,Chen J,Guo F

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Mon May 01 00:00:00 EDT 2023

Sustained release of therapeutic gene by injectable hydrogel for hepatocellular carcinoma.

International journal of pharmaceutics: X

Xu S,Cai J,Cheng H,Wang W

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Fri Dec 15 00:00:00 EST 2023

Contribution of Mesenchymal Stem Cells from Obese Adipose Tissue to PD-L1 Over-Expression and Breast Cancer Progression through Pathogenic Th17 Cell Activation.

Cancers

Blangero F,Robert M,Andraud T,Dumontet C,Vidal H,Eljaafari A

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Mon May 29 00:00:00 EDT 2023

BRAF D594A mutation defines a unique biological and immuno-modulatory subgroup associated with functional CD8⁺ T cell infiltration in colorectal cancer.

Journal of translational medicine

Li W,Zhao C,Li W,Gong Y,Ma K,Lu Y,Liu X,Zhang L,Guo F

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Wed Oct 18 00:00:00 EDT 2023

Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.

NPJ breast cancer

Teo ZL,O'Connor MJ,Versaci S,Clarke KA,Brown ER,Percy LW,Kuykhoven K,Mintoff CP,Savas P,Virassamy B,Luen SJ,Byrne A,Sant S,Lindeman GJ,Darcy PK,Loi S

25-5982-82 was used in Flow cytometry/Cell sorting to identify baseline tumour-infiltrating lymphocyte (TIL) levels as a potential predictive biomarker of response to PARPi, WEE1i and immunotherapies in BRCA1/2 wild-type TNBC.

Tue Aug 15 00:00:00 EDT 2023

Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer.

Journal for immunotherapy of cancer

Mao M,Chen Y,Yang J,Cheng Y,Xu L,Ji F,Zhou J,Zhang X,Li Z,Chen C,Ju S,Zhang J,Wang L

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Thu Dec 01 00:00:00 EST 2022

Heterogeneity of tyrosine-based melanin anabolism regulates pulmonary and cerebral organotropic colonization microenvironment of melanoma cells.

Theranostics

Wang X,Chen Y,Lan B,Wang Y,Lin W,Jiang X,Ye J,Shang B,Feng C,Liu J,Zhai J,Xu M,Li Q,Lin L,Hu M,Zheng F,Chen L,Shao C,Wang Y,Shi Y

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Thu Apr 21 00:00:00 EDT 2022

CD4⁺ CTLs Act as a Key Effector Population for Allograft Rejection of MSCs in a Donor MHC-II Dependent Manner in Injured Liver.

Aging and disease

Shen S,Li Y,Jin M,Fan D,Pan R,Lin A,Chen Y,Xiang L,Zhao RC,Shao J

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Thu Dec 01 00:00:00 EST 2022

5-Azacytidine-Mediated Modulation of the Immune Microenvironment in Murine Acute Myeloid Leukemia.

Cancers

Ebelt ND,Manuel ER

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Sun Dec 25 00:00:00 EST 2022

Isotope tracing reveals distinct substrate preference in murine melanoma subtypes with differing anti-tumor immunity.

Cancer & metabolism

Zhang X,Halberstam AA,Zhu W,Leitner BP,Thakral D,Bosenberg MW,Perry RJ

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Thu Dec 01 00:00:00 EST 2022

Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy.

Frontiers in immunology

Denis M,Mathé D,Micoud M,Choffour PA,Grasselly C,Matera EL,Dumontet C

25-5982-82 was used in flow cytometry to demonstrate several differences between SC and orthotopic models at basal state, which tend to become similar after therapy.

Tue Jan 31 00:00:00 EST 2023

Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents.

Journal of nanobiotechnology

Hagemans IM,Wierstra PJ,Steuten K,Molkenboer-Kuenen JDM,van Dalen D,Ter Beest M,van der Schoot JMS,Ilina O,Gotthardt M,Figdor CG,Scheeren FA,Heskamp S,Verdoes M

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Wed Feb 02 00:00:00 EST 2022

Non-synergy of PD-1 blockade with T-cell therapy in solid tumors.

Journal for immunotherapy of cancer

Davies JS,Karimipour F,Zhang L,Nagarsheth N,Norberg S,Serna C,Strauss J,Chiou S,Gulley JL,Hinrichs CS

25-5982-82 was used in Flow cytometry/Cell sorting to support the concept that PD-1 blockade acts primarily through endogenous rather than transferred T cells to mediate a non-synergistic antitumor effect in solid tumor cell therapy.

Fri Jul 01 00:00:00 EDT 2022

Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer.

Oncogene

Cen B,Wei J,Wang D,Xiong Y,Shay JW,DuBois RN

25-5982-82 was used in Flow cytometry/Cell sorting to demonstrate that mutations in the adenomatous polyposis coli (APC) gene lead to colonic epithelial cell resistance to CD8+ T cell cytotoxicity by induction of PD-L1 expression.

Fri Oct 01 00:00:00 EDT 2021

Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study.

Clinical and molecular hepatology

Yoo GS,Ahn WG,Kim SY,Kang W,Choi C,Park HC

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Fri Jan 01 00:00:00 EST 2021

Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8⁺ PD-1^- tumor-infiltrating T cells in PD-L1-enriched tumor microenvironment.

International journal of cancer

Eissa IR,Mukoyama N,Abdelmoneim M,Naoe Y,Matsumura S,Bustos-Villalobos I,Ichinose T,Miyajima N,Morimoto D,Tanaka M,Fujimoto Y,Sone M,Kodera Y,Kasuya H

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Thu Jul 01 00:00:00 EDT 2021

Collagenase-Expressing Salmonella Targets Major Collagens in Pancreatic Cancer Leading to Reductions in Immunosuppressive Subsets and Tumor Growth.

Cancers

Ebelt ND,Zamloot V,Zuniga E,Passi KB,Sobocinski LJ,Young CA,Blazar BR,Manuel ER

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Fri Jul 16 00:00:00 EDT 2021

Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade.

JCI insight

Ferrere G,Tidjani Alou M,Liu P,Goubet AG,Fidelle M,Kepp O,Durand S,Iebba V,Fluckiger A,Daillère R,Thelemaque C,Grajeda-Iglesias C,Alves Costa Silva C,Aprahamian F,Lefevre D,Zhao L,Ryffel B,Colomba E,Arnedos M,Drubay D,Rauber C,Raoult D,Asnicar F,Spector T,Segata N,Derosa L,Kroemer G,Zitvogel L

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Mon Jan 25 00:00:00 EST 2021

USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade.

Nature communications

Yang Z,Xu G,Wang B,Liu Y,Zhang L,Jing T,Tang M,Xu X,Jiao K,Xiang L,Fu Y,Tang D,Zhang X,Jin W,Zhuang G,Zhao X,Liu Y

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Wed Aug 11 00:00:00 EDT 2021

USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade.

Nature communications

Yang Z,Xu G,Wang B,Liu Y,Zhang L,Jing T,Tang M,Xu X,Jiao K,Xiang L,Fu Y,Tang D,Zhang X,Jin W,Zhuang G,Zhao X,Liu Y

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Wed Aug 11 00:00:00 EDT 2021

Fascin inhibitor increases intratumoral dendritic cell activation and anti-cancer immunity.

Cell reports

Wang Y,Song M,Liu M,Zhang G,Zhang X,Li MO,Ma X,Zhang JJ,Huang XY

25-5982-82 was used in Flow Cytometry to investigate the effects of fascin blockade in anti-tumor immune responses in syngeneic mouse models of various cancers.

Tue Apr 06 00:00:00 EDT 2021

Antigen-Capturing Mesoporous Silica Nanoparticles Enhance the Radiation-Induced Abscopal Effect in Murine Hepatocellular Carcinoma Hepa1-6 Models.

Pharmaceutics

Yang K,Choi C,Cho H,Ahn WG,Kim SY,Shin SW,Kim Y,Jang T,Lee N,Park HC

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Fri Oct 29 00:00:00 EDT 2021

Downregulation of PD-L1 via amide analogues of brefelamide: Alternatives to antibody-based cancer immunotherapy.

Experimental and therapeutic medicine

Zhang J,Yamada O,Kida S,Murase S,Hattori T,Oshima Y,Kikuchi H

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Wed Apr 01 00:00:00 EDT 2020

Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammation.

Journal for immunotherapy of cancer

Wu B,Chiang HC,Sun X,Yuan B,Mitra P,Hu Y,Curiel TJ,Li R

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Sat Aug 01 00:00:00 EDT 2020

Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms.

Journal for immunotherapy of cancer

Neuwelt AJ,Kimball AK,Johnson AM,Arnold BW,Bullock BL,Kaspar RE,Kleczko EK,Kwak JW,Wu MH,Heasley LE,Doebele RC,Li HY,Nemenoff RA,Clambey ET

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Wed Apr 01 00:00:00 EDT 2020

Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy.

Journal for immunotherapy of cancer

Gao H,Wu Y,Shi J,Zhang X,Liu T,Hu B,Jia B,Wan Y,Liu Z,Wang F

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Sun Nov 01 00:00:00 EDT 2020

GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism.

Cancer cell

Mondragón L,Mhaidly R,De Donatis GM,Tosolini M,Dao P,Martin AR,Pons C,Chiche J,Jacquin M,Imbert V,Proïcs E,Boyer L,Doye A,Luciano F,Neels JG,Coutant F,Fabien N,Sormani L,Rubio-Patiño C,Bossowski JP,Muller F,Marchetti S,Villa E,Peyron JF,Gaulard P,Lemonnier F,Asnafi V,Genestier L,Benhida R,Fournié JJ,Passeron T,Ricci JE,Verhoeyen E

25-5982-82 was used in Flow Cytometry to suggest the therapeutic potential of targeting NF-κB signaling in AITL and provide a model for future AITL therapeutic investigations.

Mon Sep 16 00:00:00 EDT 2019

Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer.

Molecular oncology

Zhou Z,Chen H,Xie R,Wang H,Li S,Xu Q,Xu N,Cheng Q,Qian Y,Huang R,Shao Z,Xiang M

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Mon Apr 01 00:00:00 EDT 2019

PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.

The Journal of clinical investigation

Zamarin D,Ricca JM,Sadekova S,Oseledchyk A,Yu Y,Blumenschein WM,Wong J,Gigoux M,Merghoub T,Wolchok JD

25-5982 was used in Flow cytometry/Cell sorting to use human tumour histocultures and syngeneic tumour models treated with Newcastle disease virus to identify immune targets upregulated by OV treatment.

Mon Apr 02 00:00:00 EDT 2018

PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.

The Journal of clinical investigation

Zamarin D,Ricca JM,Sadekova S,Oseledchyk A,Yu Y,Blumenschein WM,Wong J,Gigoux M,Merghoub T,Wolchok JD

Mon Apr 02 00:00:00 EDT 2018

PD-1/PD-L1 regulates Treg differentiation in pregnancy-induced hypertension.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas

Jiang L,Tang C,Gong Y,Liu Y,Rao J,Chen S,Qu W,Wu D,Lei L,Chen L

25-5982 was used in Flow cytometry to study the relationship between PD-1/PD-L1 and regulatory T cell differentiation in pregnancy-induced hypertension.

Mon Jun 25 00:00:00 EDT 2018

Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion.

Nature communications

Sun C,Lan P,Han Q,Huang M,Zhang Z,Xu G,Song J,Wang J,Wei H,Zhang J,Sun R,Zhang C,Tian Z

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Wed Mar 28 00:00:00 EDT 2018

MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity.

JCI insight

Lee-Sherick AB,Jacobsen KM,Henry CJ,Huey MG,Parker RE,Page LS,Hill AA,Wang X,Frye SV,Earp HS,Jordan CT,DeRyckere D,Graham DK

25-5982 was used in Flow cytometry/Cell sorting to demonstrate both the direct therapeutic effects of MERTK inhibition on leukaemia cells and the induction of anti-leukaemia immunity via suppression of the coinhibitory PD-1 axis.

Fri Nov 02 00:00:00 EDT 2018

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.

Immunity

Coelho MA,de Carné Trécesson S,Rana S,Zecchin D,Moore C,Molina-Arcas M,East P,Spencer-Dene B,Nye E,Barnouin K,Snijders AP,Lai WS,Blackshear PJ,Downward J

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Tue Dec 19 00:00:00 EST 2017

Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition.

Oncotarget

Peer S,Baier G,Gruber T

25-5982 was used in Flow cytometry/Cell sorting to show that Cblb-/- T cells are less susceptible to PD-L1-mediated suppression of T cell proliferation and IFNγ secretion.

Tue Jun 27 00:00:00 EDT 2017

Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response.

Scientific reports

Soukup K,Halfmann A,Dillinger B,Poyer F,Martin K,Blauensteiner B,Kauer M,Kuttke M,Schabbauer G,Dohnal AM

25-5982 was used in Flow cytometry/Cell sorting to suggest that MAPK-activated protein kinase 2 deletion leads to an expansion of stimulatory CD103+ dendritic cells, mounting a potent CD8+ T cell anti-tumour response in mice.

Mon Sep 18 00:00:00 EDT 2017

Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission.

Immunity

Tian Y,Kuo CF,Akbari O,Ou JH

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Tue May 17 00:00:00 EDT 2016

Ex vivo expanded hematopoietic stem cells overcome the MHC barrier in allogeneic transplantation.

Cell stem cell

Zheng J,Umikawa M,Zhang S,Huynh H,Silvany R,Chen BP,Chen L,Zhang CC

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Fri Aug 05 00:00:00 EDT 2011

Farnesyltransferase inhibitor FTI-277 reduces mortality of septic mice along with improved bacterial clearance.

The Journal of pharmacology and experimental therapeutics

Yang W,Yamada M,Tamura Y,Chang K,Mao J,Zou L,Feng Y,Kida K,Scherrer-Crosbie M,Chao W,Ichinose F,Yu YM,Fischman AJ,Tompkins RG,Yao S,Kaneki M

Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 25-5982-82) in Flow Cytometry

Thu Dec 01 00:00:00 EST 2011

A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.

Cell research

Sheng H,Wang Y,Jin Y,Zhang Q,Zhang Y,Wang L,Shen B,Yin S,Liu W,Cui L,Li N

Fri Aug 01 00:00:00 EDT 2008

Bioinformatics

Protein Aliases: B7 homolog 1; B7-H1; CD274; PD-L1; PDCD1 ligand 1; pdl-1; Programmed cell death 1 ligand 1; programmed death ligand 1; sCD274; soluble CD274; soluble PD L1; sPD L1

View more View less

Gene Aliases: A530045L16Rik; B7h1; Cd274; Pdcd1l1; Pdcd1lg1; Pdl1

View more View less

UniProt ID: (Mouse) Q9EP73

View more View less

Entrez Gene ID: (Mouse) 60533

View more View less

Function(s)

protein binding immunoglobulin receptor superfamily

Process(es)

immune response signal transduction cell surface receptor signaling pathway positive regulation of cell migration T cell costimulation negative regulation of interferon-gamma production negative regulation of interleukin-10 production positive regulation of T cell proliferation negative regulation of T cell proliferation negative regulation of activated T cell proliferation toxin transport negative regulation of tumor necrosis factor superfamily cytokine production positive regulation of interleukin-10 secretion

Performance Guarantee

If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*

Learn more

CD274 (PD-L1, B7-H1) Monoclonal Antibody (MIH5), PE-Cyanine7, eBioscience™

CD274 (PD-L1, B7-H1) Antibody (25-5982-82) in Flow

Product Details

25-5982-82

Flow Cytometry (Flow)

Species Reactivity

Published species

Host/Isotype

Recommended Isotype Control

Class

Type

Clone

Conjugate

Excitation/Emission Max

Form

Concentration

Purification

Storage buffer

Contains

Storage conditions

Shipping conditions

RRID

Product Specific Information

Target Information

How to use the Panel Builder

Bioinformatics

Performance Guarantee

We're here to help

Your items have has been added!